ClinicalTrials.gg
RecruitingNCT07702448Updated Jul 16, 2026

Changes in Depression and Esthetic Perception After Orthognathic Surgery

An observational study in Dentofacial Deformities, Malocclusions and Orthognathic Surgery, sponsored by Kırıkkale University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Kırıkkale University · Observational

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
18
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study aims to evaluate changes in depressive symptoms and subjective esthetic perception before and after bimaxillary orthognathic surgery in patients with different types of malocclusion. The study will analyze anonymized clinical data and questionnaire responses to assess the impact of orthognathic surgery on psychological well-being and esthetic perception.

Read the detailed description

This prospective observational study aims to investigate changes in depressive symptoms and subjective esthetic perception in patients with different types of malocclusion undergoing bimaxillary orthognathic surgery. Participants will be evaluated before surgery and during the postoperative follow-up using validated assessment questionnaires.

The study will analyze anonymized data obtained from routine clinical records and patient-reported questionnaires. Variables to be collected include age, sex, occupation, educational level, social media use, and patients' subjective perceptions of esthetics and depressive symptoms. The findings will contribute to a better understanding of the psychological and esthetic outcomes associated with orthognathic surgery and may help optimize patient evaluation and treatment planning.

02

Conditions studied

  • Dentofacial Deformities
  • Malocclusions
  • Orthognathic Surgery

Keywords

  • Orthognathic Surgery
  • Bimaxillary Surgery
  • Dentofacial Deformity
  • Quality of Life
  • Psychological Outcomes
  • Beck Depression Inventory-II
  • Rosenberg Self-Esteem Scale
  • Orthognathic Quality of Life Questionnaire
03

In context

Dentofacial Deformities

40 studies on the registry are indexed under Dentofacial Deformities; 16 are open to participants now.

This study's planned enrollment of 18 is below the median of 45 across 15 observational studies indexed under Dentofacial Deformities.

Browse Dentofacial Deformities studies →

Lead sponsor

Kırıkkale University is the lead sponsor of 114 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adult patients aged 18-40 years with different types of malocclusion who are scheduled to undergo bimaxillary orthognathic surgery at the Faculty of Dentistry, Kırıkkale University. Eligible participants will be evaluated 1 week before surgery and 6 months after surgery using validated patient-reported outcome measures assessing depressive symptoms, self-esteem, and orthognathic quality of life.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 40 years.
  • Individuals without systemic diseases.
  • Patients with an indication for bimaxillary orthognathic surgery.
  • Patients who complete the study questionnaires 1 week before surgery and 6 months after surgery.
  • Individuals who use at least one of the following social media platforms: Instagram, WhatsApp, Snapchat, X, TikTok, or Telegram.
  • Individuals who provide written to participate in the study.
  • Patients scheduled to undergo treatment at the Faculty of Dentistry, Kırıkkale University.

Exclusion criteria

Exclusion Criteria:

  • Patients without an indication for bimaxillary orthognathic surgery or those undergoing single-jaw surgery only.
  • Individuals with systemic diseases (e.g., diabetes mellitus, hypertension, or thyroid disorders).
  • Patients with a diagnosed psychiatric disorder.
  • Patients with a history of previous orthognathic surgery.
  • Patients scheduled to undergo additional esthetic procedures (e.g., genioplasty, botulinum toxin injection, or dermal filler treatment).
  • Individuals who decline to participate or do not provide written .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
18 participants (estimated)
Patient registry
No

Groups and cohorts

  • Skeletal Class I Malocclusion

    Participants with skeletal Class I malocclusion undergoing bimaxillary orthognathic surgery. Changes in depressive symptoms, self-esteem, esthetic perception, and orthognathic quality of life will be evaluated before and after surgery.

  • Skeletal Class II Malocclusion

    Participants with skeletal Class II malocclusion undergoing bimaxillary orthognathic surgery. Changes in depressive symptoms, self-esteem, esthetic perception, and orthognathic quality of life will be evaluated before and after surgery.

  • Skeletal Class III Malocclusion

    Participants with skeletal Class III malocclusion undergoing bimaxillary orthognathic surgery. Changes in depressive symptoms, self-esteem, esthetic perception, and orthognathic quality of life will be evaluated before and after surgery.

06

What researchers measure

Primary outcomes

  1. Change in Depressive Symptoms

    Change in depressive symptom scores measured using the Beck Depression Inventory-II (BDI-II) between the preoperative assessment (1 week before surgery) and the postoperative assessment (6 months after surgery). BDI-II is a 21-item self-report instrument used to assess the severity of depressive symptoms. Each item is scored on a scale from 0 to 3, yielding a total score ranging from 0 to 63. Higher total scores indicate greater severity of self-reported depressive symptoms. BDI-II total scores are interpreted as follows: 0-13 indicates minimal, 14-19 mild, 20-28 moderate, and 29-63 severe levels of depressive symptoms.

    Time frame: 1 week before surgery and 6 months after surgery

  2. Change in Quality of Life

    Change in quality of life measured using the Orthognathic Quality of Life Questionnaire (OQLQ) between the preoperative assessment (1 week before surgery) and the postoperative assessment (6 months after surgery). OQLQ is a 22-item self-report instrument developed to assess the impact of dentofacial deformities on patients' quality of life. Each item is scored on a scale from 0 to 4, where a score of 0 indicates that the relevant condition does not bother the patient, while higher scores reflect increasing levels of concern. The item scores are summed to obtain a total score ranging from 0 to 88. Higher total scores indicate a greater negative impact of dentofacial deformity on quality of life and, consequently, poorer quality of life, whereas lower scores indicate better quality of life.

    Time frame: 1 week before surgery and 6 months after surgery

  3. Change in Self-Esteem

    Change in self-esteem scores measured using the Rosenberg Self-Esteem Scale (RSES) between the preoperative assessment (1 week before surgery) and the postoperative assessment (6 months after surgery). RSES is a 10-item self-report instrument developed to assess individuals' global self-esteem and overall sense of self-worth. The scale consists of five positively worded and five negatively worded items, with responses rated on a four-point scale. In the Turkish version adapted by Çuhadaroğlu, responses are evaluated using a Guttman-based scoring system, yielding a total score ranging from 0 to 6. Higher total scores indicate lower levels of self-esteem, whereas lower scores indicate higher levels of self-esteem. Total scores are interpreted as follows: 0-1 indicates high, 2-4 moderate, and 5-6 low levels of self-esteem.

    Time frame: 1 week before surgery and 6 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data, including demographic characteristics, social media usage, Beck Depression Inventory-II (BDI-II) scores, Rosenberg Self-Esteem Scale (RSES) scores, and Orthognathic Quality of Life Questionnaire (OQLQ) results, will be made available upon reasonable request to the corresponding author after publication of the study results.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2026
First posted
Jul 14, 2026
StartActual
Jun 20, 2026
Primary completionEst.
Jun 20, 2027
CompletionEst.
Jul 20, 2027
Last update
Jul 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07702448
Responsible party
Elif Çoban (Assistant Professor, Kırıkkale University) — Principal investigator
First posted
Jul 14, 2026
Start date
Jun 20, 2026
Primary completion
Jun 20, 2027 (estimated)
Completion
Jul 20, 2027 (estimated)
Last update
Jul 16, 2026

Study contacts

Elif Assistant Professor, DDS
Contact
elifcoban@kku.edu.tr
+90 318 224 4927 ext. 71
Murat Rıfat Research Asistant, DDS
Contact
muratyalinkilic5@gmail.com
+90 318 2244927 ext. 7130
Elif Çoban, DDS
principal investigator · Kırıkkale University Faculty of Dentistry

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion